Heartflow (NASDAQ:HTFL) CFO Sells $379,783.69 in Stock

by · The Markets Daily

Heartflow, Inc. (NASDAQ:HTFL – Get Free Report) CFO Vikram Verghese sold 7,579 shares of the stock in a transaction on Thursday, September 17th. The stock was sold at an average price of $50.11, for a total transaction of $379,783.69. Following the transaction, the chief financial officer owned 171,949 shares in the company, valued at approximately $8,616,364.39. This trade represents a 4.22% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Vikram Verghese also recently made the following trade(s):

  • On Friday, September 18th, Vikram Verghese sold 16,766 shares of Heartflow stock. The shares were sold at an average price of $50.75, for a total transaction of $850,874.50.
  • On Tuesday, September 15th, Vikram Verghese sold 668 shares of Heartflow stock. The stock was sold at an average price of $50.01, for a total transaction of $33,406.68.
  • On Monday, September 14th, Vikram Verghese sold 4,593 shares of Heartflow stock. The stock was sold at an average price of $50.24, for a total transaction of $230,752.32.
  • On Friday, September 11th, Vikram Verghese sold 29,714 shares of Heartflow stock. The stock was sold at an average price of $50.06, for a total value of $1,487,482.84.
  • On Tuesday, September 8th, Vikram Verghese sold 6,640 shares of Heartflow stock. The stock was sold at an average price of $50.03, for a total value of $332,199.20.
  • On Thursday, September 3rd, Vikram Verghese sold 27,540 shares of Heartflow stock. The shares were sold at an average price of $49.69, for a total value of $1,368,462.60.
  • On Wednesday, September 2nd, Vikram Verghese sold 5,876 shares of Heartflow stock. The shares were sold at an average price of $50.60, for a total value of $297,325.60.

Heartflow Stock Up 2.4%

HTFL traded up $1.18 on Friday, hitting $50.75. The company had a trading volume of 6,606,910 shares, compared to its average volume of 1,824,326. The company’s fifty day moving average price is $37.75 and its 200 day moving average price is $31.70. Heartflow, Inc. has a 1-year low of $20.13 and a 1-year high of $52.22.

Heartflow (NASDAQ:HTFL – Get Free Report) last announced its quarterly earnings results on Thursday, August 13th. The company reported ($0.07) EPS for the quarter, beating the consensus estimate of ($0.22) by $0.15. Heartflow had a negative return on equity of 23.52% and a negative net margin of 55.82%.The company had revenue of $64.08 million for the quarter. The company’s revenue was up 47.7% compared to the same quarter last year. Research analysts forecast that Heartflow, Inc. will post -0.75 EPS for the current year.

Institutional Investors Weigh In On Heartflow

Hedge funds have recently made changes to their positions in the stock. XXEC Inc. acquired a new position in Heartflow in the 2nd quarter valued at approximately $2,524,764,000. BlackRock Inc. bought a new stake in shares of Heartflow during the second quarter valued at approximately $152,502,000. Bamco Inc. NY bought a new position in Heartflow in the second quarter worth $94,625,000. Jupiter Topco LLC acquired a new stake in Heartflow during the second quarter worth $70,983,000. Finally, Janus Henderson Group PLC increased its holdings in Heartflow by 152.0% in the 1st quarter. Janus Henderson Group PLC now owns 2,180,976 shares of the company’s stock valued at $53,063,000 after buying an additional 1,315,416 shares during the period.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on HTFL. UBS Group began coverage on shares of Heartflow in a research report on Wednesday, September 9th. They set a “neutral” rating and a $55.00 target price for the company. Wells Fargo & Company lifted their price objective on Heartflow from $37.00 to $39.00 and gave the stock an “overweight” rating in a research note on Friday, August 14th. JPMorgan Chase & Co. increased their target price on Heartflow from $35.00 to $45.00 and gave the company an “overweight” rating in a research note on Friday, August 14th. Stifel Nicolaus raised their target price on Heartflow from $40.00 to $45.00 and gave the company a “buy” rating in a report on Friday, August 14th. Finally, Piper Sandler reiterated an “overweight” rating and set a $45.00 price target (up from $38.00) on shares of Heartflow in a report on Friday, August 14th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Heartflow currently has a consensus rating of “Moderate Buy” and an average target price of $44.88.

Get Our Latest Analysis on HTFL

About Heartflow

(Get Free Report)

Heartflow, Inc is a medical technology company that develops artificial intelligence and imaging solutions for the diagnosis and management of coronary artery disease. Its platform analyzes data from coronary computed tomography angiography (CCTA) scans to create personalized, three-dimensional models of a patient’s coronary arteries.

The company’s primary offering, Heartflow Analysis, is designed to provide noninvasive estimates of fractional flow reserve derived from computed tomography (FFRCT).

See Also